USPTO Examiner HAWTHORNE OPHELIA ALTHEA - Art Unit 3786

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19063464REVERSIBLE OCCLUSION DEVICE, SYSTEM AND METHODFebruary 2025October 2025Allow810YesNo
18849936PROLAPSE CORRECTIVE DEVICESeptember 2024December 2025Allow1500YesNo
18792215APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODYAugust 2024March 2025Allow711YesNo
18775340Male Condom and Ring KitJuly 2024June 2025Allow1120YesNo
18773062METHODS AND MECHANISMS FOR MAINTAINING AN ELECTRO-ACTIVE POLYMER IN A PRE-STRETCH STATE AND USES THEREOFJuly 2024August 2025Abandon1310NoNo
18728738PATCH FOR FEMALE GENITAL AREAJuly 2024February 2026Allow2010NoNo
18721443METHOD FOR PUTTING ON AN ORTHOSIS, AND ORTHOSISJune 2024February 2026Allow2010NoNo
18741081Leveling Drape for Endovascular ProceduresJune 2024December 2025Allow1810NoNo
18735250IUD INSERTION DEVICES WITH A ROTATABLE STRING CONTROLLER AND METHODSJune 2024May 2025Allow1110NoNo
18716730ADJUSTABLE FINGER SPLINTJune 2024March 2026Allow2101YesNo
18676870PRESSURE-MITIGATION APPARATUSES FOR IMPROVED TREATMENT OF RESPIRATORY ILLNESSES AND ASSOCIATED SYSTEMS AND METHODSMay 2024March 2025Allow1010NoNo
18664755KNEE BRACE APPARATUSMay 2024August 2025Allow1500NoNo
18656072HIP RELOCATION APPARATUSMay 2024November 2024Allow610YesNo
18706422UPPER LIMB STABILIZING APPARATUSMay 2024February 2026Allow2110NoNo
18648168SYSTEM AND METHOD FOR DELIVERING A THERAPY AND SENSING A BIOLOGICAL ACTIVITY IN THE MOUTHApril 2024May 2025Abandon1310NoNo
18637118Pain Management and Post-Operative Hip OrthosisApril 2024March 2025Allow1110NoNo
18701488CHILDBIRTH SUPPORT APPARATUSApril 2024December 2025Allow2000NoNo
18700242APPARATUS FOR SPINAL SEGMENTATIONApril 2024February 2026Allow2200NoNo
18628279MEDICAL DEVICE HAVING A POLYMERIC NANOCOMPOSITE ACTIVELY CONTROLLED FOR RAPID HEALING OF FRACTURES AND SOFT TISSUE INJURYApril 2024December 2025Allow2010NoNo
18626186APPARATUS AND METHOD FOR EVERTING CATHETER FOR IUD DELIVERY AND PLACEMENT IN THE UTERINE CAVITYApril 2024May 2025Allow1310NoNo
18619308HEMORRHAGE CONTROL DEVICEMarch 2024November 2024Allow810NoNo
18614829Genital Protective Device with Enhanced STD PreventionMarch 2024February 2026Abandon2310YesNo
18691980INTRAUTERINE 3-DIMENSIONAL DEVICE AND SYSTEM THEREOFMarch 2024February 2026Abandon2310NoNo
18598368KNEE BRACE FOR THE TREATMENT OF GONARTHROSISMarch 2024October 2025Allow2010NoNo
18444184Spinal Decompression Rack with Artificial IntelligenceFebruary 2024February 2026Allow2410NoNo
18441582HEAD-MOUNTED EARMUFF DEVICEFebruary 2024February 2026Allow2410NoNo
18681687INGROWN FINGERNAIL/TOENAIL CORRECTION DEVICE USING SHAPE MEMORY ALLOYFebruary 2024December 2025Allow2210NoNo
18294965Loading Base for Facial Protection DevicesFebruary 2024October 2025Allow2010NoNo
18430698INTERNAL CONDOM METHOD AND DEVICEFebruary 2024September 2025Allow1910NoNo
18418300REVERSIBLE MALE CONTRACEPTIVE IMPLANT DEVICEJanuary 2024August 2025Allow1910YesNo
18416934EXTERNAL SPINAL BRACEJanuary 2024June 2025Allow1720YesNo
18410147Wound Bolster Dressing and Method of UseJanuary 2024November 2025Allow2210NoNo
18400466OCCLUSIVE IMPLANT COMPOSITIONSDecember 2023November 2025Allow2311NoNo
18394333INFLATION CONTROL VALVEDecember 2023January 2025Allow1310NoNo
18527053Hip Flexion Contracture Therapeutic Medical DeviceDecember 2023February 2026Allow2610NoNo
18522395ANKLE FOOT ORTHOSISNovember 2023October 2025Allow2200NoNo
18515582Strap System for Facilitating Cannulation in Obese PatientsNovember 2023December 2025Abandon2410NoNo
18511470INTRAUTERINE CONTRACEPTIVE DEVICENovember 2023October 2025Allow2320NoNo
18559486BACK SUPPORT BELTNovember 2023October 2025Allow2310YesNo
18502807SURGICAL UNIVERSAL HEADREST INCLUDING SKULL PIN HOLDER ASSEMBLYNovember 2023May 2025Allow1821NoNo
18386589PUNCTURE WOUND DRESSING INSERTION PROCESSNovember 2023August 2024Allow1010NoNo
18383198OrthosisOctober 2023March 2025Allow1721NoNo
18287863APPARATUS AND METHOD FOR AN EARPIECEOctober 2023December 2024Allow1411NoNo
18555518WEARABLE PERINEUM LEAKAGE CONTROL DEVICEOctober 2023February 2026Allow2810NoNo
18480930Head Stabilization System and Method with Arc FeaturesOctober 2023August 2025Allow2210YesNo
18478290METHODS AND DEVICES TO PREVENT PREMATURE BIRTHSeptember 2023December 2024Allow1410YesNo
18373153SURGICAL ROBOTIC INSTRUMENT SHIELDSeptember 2023November 2024Abandon1410NoNo
18473248PENIS ENLARGEMENT DEVICESeptember 2023January 2024Allow410NoNo
18464226IUD REMOVAL DEVICES, AND RELATED METHODS AND KITSSeptember 2023October 2025Allow2500NoNo
18464146Male Condom and Ring KitSeptember 2023June 2024Allow920YesNo
18279495RARE-EARTH CATALYSED POLYISOPRENE ARTICLESAugust 2023March 2026Allow3111YesNo
18264444PACKAGED LUBRICATED CONDOMAugust 2023November 2025Allow2710NoNo
18363538SELF-ATTACHING ABSORBENT WRAPAugust 2023April 2024Allow811NoNo
18360443ORTHOTIC KNEE CONTROL DEVICE FOR PROVIDING EASE OF MOVEMENTJuly 2023December 2025Allow2810NoNo
18225608BILATERAL COMPRESSION DEVICEJuly 2023October 2024Abandon1410NoNo
18350052DEVICE AND METHOD FOR PROTECTING A FETUS FROM INJURY DURING UMBILICAL CORD PROLAPSEJuly 2023December 2025Abandon2910NoNo
18035387CONTRACEPTION APPARATUS FOR MALEJune 2023August 2025Allow2810NoNo
18212965ORTHOPEDIC WALKING BOOT HAVING A MECHANICALLY ADJUSTABLE RAMP INSERTJune 2023August 2024Allow1410NoNo
18338118METHODS AND MECHANISMS FOR MAINTAINING AN ELECTRO-ACTIVE POLYMER IN A PRE-STRETCH STATE AND USES THEREOFJune 2023September 2024Abandon1510NoNo
18206322Phase Change Material for Thermal Therapy and Delivery of Active IngredientsJune 2023April 2025Allow2300YesNo
18325626System and Method for Fallopian Birth ControlMay 2023May 2024Allow1211YesNo
18039092SNAP BAND DRESSING DEVICES AND METHODS OF USEMay 2023January 2026Allow3220YesNo
18252791NAIL CORRECTING TOOLMay 2023October 2025Allow3010NoNo
18036539LOWER BACK PAIN TREATMENT DEVICEMay 2023January 2026Abandon3210NoNo
18315818SPLINT DEVICE AND SPLINT SYSTEM COMPRISING SAMEMay 2023October 2025Abandon2910NoNo
18195671FEMALE GENITALIA PROTECTIVE SHEATH APPARATUSMay 2023July 2025Allow2610NoNo
18312129SYSTEMS COMPRISING A COMPOSITE BACKING AND METHODS FOR LONG TERM TRANSDERMAL ADMINISTRATIONMay 2023August 2024Allow1510NoNo
18302571Female Universal Condom DeviceApril 2023November 2025Abandon3110NoNo
18135176FOOT PROTECTION SYSTEMApril 2023March 2026Abandon3520NoNo
18132820Protective and Exercise Hand Restraint System and ApparatusApril 2023May 2024Allow1410NoNo
18296086FORCE REDISTRIBUTION HINDFOOT SHOE INSERTApril 2023December 2025Allow3210NoNo
18295825SYSTEMS AND METHODS FOR LONG TERM TRANSDERMAL ADMINISTRATIONApril 2023August 2024Allow1610NoNo
18295471WRAP SYSTEM FOR IMMOBILIZING A PERSONApril 2023November 2025Abandon3210NoNo
18125110Medical Vaporizer with Precision Controlled Vapor CompositionMarch 2023December 2025Allow3300NoNo
18181655ORAL APPLIANCEMarch 2023August 2024Allow1810NoNo
18174786WEARABLE PHALLIC LUBRICATION DELIVERY SYSTEMFebruary 2023October 2025Abandon3210NoNo
18023473TELETHERAPY PATIENT SUPPORT AND METHODFebruary 2023September 2025Allow3110NoNo
18023150IMPLANTABLE TUBE VALVEFebruary 2023August 2025Allow3020NoNo
18021616CORRECTIVE APPARATUS FOR DEFORMED EXTERNAL EARFebruary 2023October 2025Allow3210YesNo
18108702THREE DIMENSIONAL DEVICES AND METHODS FOR PROLAPSE ALLEVIATIONFebruary 2023September 2025Allow3110NoNo
18020818METHOD FOR PRODUCING PATIENT-CUSTOMIZED PESSARY USING 3D PRINTER AND PATIENT-CUSTOMIZED PESSARY PRODUCED THEREBYFebruary 2023June 2025Allow2810NoNo
18104133PAIN MANAGEMENT AND POST-OPERATIVE HIP ORTHOSISJanuary 2023January 2024Allow1210NoNo
18159185DEVICE AND METHOD FOR REVERSIBLE OCCLUSION OF BODY LUMENSJanuary 2023October 2025Abandon3301NoNo
18156268APPARATUS AND METHOD FOR EVERTING CATHETER FOR IUD DELIVERY AND PLACEMENT IN THE UTERINE CAVITYJanuary 2023May 2024Abandon1610NoNo
18094323OPTIONAL SHAPED RECTOCELE PADDLESJanuary 2023December 2023Allow1210YesNo
18014612A PERSONAL CARE DEVICEJanuary 2023September 2025Allow3210NoNo
18093616SLING DEVICE FOR SUPPORTING THE LEG AND FOOT OF A USER AND METHODS OF MAKING AND USING THE SAMEJanuary 2023August 2025Abandon3110NoNo
18092568NAIL CORRECTION KITJanuary 2023July 2025Allow3010YesNo
18076844INFLATABLE STENT FOR MEDICAL TREATMENTDecember 2022October 2025Allow3401NoNo
18075935Ankle Support Device For Walking TherapyDecember 2022January 2026Allow3720YesNo
17927987A FALLOPIAN TUBE RETRIEVABLE DEVICENovember 2022March 2025Allow2810NoNo
18058289IUD INSERTION DEVICES WITH STRING CONTROLNovember 2022February 2025Allow2710YesNo
17987190METHODS AND DEVICES FOR SKIN TIGHTENINGNovember 2022February 2024Allow1510NoNo
17983743BACK SUPPORT DEVICENovember 2022October 2025Allow3601YesNo
17983010LYOPHILIZED HYDROGEL WOUND DRESSINGNovember 2022January 2026Allow3811NoNo
17980303ACCESSORY DEVICE, A PATIENT IMMOBILIZATION SYSTEM, AND A METHOD OF FORMING A PATIENT IMMOBILIZATION SYSTEMNovember 2022January 2024Allow1410NoNo
17980032PROTECTIVE FEMALE HYGIENE DEVICENovember 2022May 2025Abandon3010NoNo
17979689Adjustable Exoskeleton Foot-Supporting Appendage for Variable Human Kinematic CompatibilityNovember 2022September 2024Abandon2221NoNo
17978333System & Method for Providing a Reconfigurable SlingNovember 2022June 2025Allow3200NoNo
17921733KNITTED LOOPS FOR MASKS OR GARMENTSOctober 2022October 2025Abandon3501NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HAWTHORNE, OPHELIA ALTHEA.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
10
Examiner Affirmed
7
(70.0%)
Examiner Reversed
3
(30.0%)
Reversal Percentile
47.0%
Lower than average

What This Means

With a 30.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
35
Allowed After Appeal Filing
10
(28.6%)
Not Allowed After Appeal Filing
25
(71.4%)
Filing Benefit Percentile
43.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 28.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HAWTHORNE, OPHELIA ALTHEA - Prosecution Strategy Guide

Executive Summary

Examiner HAWTHORNE, OPHELIA ALTHEA works in Art Unit 3786 and has examined 491 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner HAWTHORNE, OPHELIA ALTHEA's allowance rate of 82.1% places them in the 54% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by HAWTHORNE, OPHELIA ALTHEA receive 1.78 office actions before reaching final disposition. This places the examiner in the 40% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HAWTHORNE, OPHELIA ALTHEA is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +18.9% benefit to allowance rate for applications examined by HAWTHORNE, OPHELIA ALTHEA. This interview benefit is in the 62% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 32.2% of applications are subsequently allowed. This success rate is in the 68% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 55.7% of cases where such amendments are filed. This entry rate is in the 82% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 58% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 69.7% of appeals filed. This is in the 56% percentile among all examiners. Of these withdrawals, 30.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 42.4% are granted (fully or in part). This grant rate is in the 34% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.8% of allowed cases (in the 65% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.9% of allowed cases (in the 85% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.